Antiinfective properties of ursolic acid-loaded chitosan nanoparticles against Staphylococcus aureus. 2021

Fatemeh Ghasemzadeh, and Ghasem D Najafpour, and Maedeh Mohammadi
Biotechnology Research Laboratory, Faculty of Chemical Engineering, Babol Noshirvani University of Technology, Babol Iran.

The present study aimed to synthesize ursolic acid-loaded chitosan nanoparticles (UA-Ch-NPs) as an antiinfective agent against 21 Staphylococcus aureus isolates. The UA-Ch-NPs were synthesized by a simple method and then characterized by TEM, FTIR, DLS-zeta potential, and XRD analyses. According to the characterization results, highly dispersed spherical nanoparticles with a mean diameter of 258 nm and a zeta potential of + 40.1 mV were developed. The antibacterial properties of UA-Ch-NPs were investigated and their inhibitory effect on biofilm formation was demonstrated by AFM. Finally, the expression levels of icaA and icaD were measured using real-time PCR. Results indicated that the minimum inhibitory concentration (MIC) of UA and UA-Ch-NPs against S. aureus was 64 and 32 µg/mL, respectively. The treatment of bacterial cells with UA-Ch-NPs significantly decreased the expression of icaA and icaD genes which are engaged in biofilm formation. Our results indicated that UA-Ch-NPs could be a promising material for antibacterial and antibiofilm applications.

UI MeSH Term Description Entries

Related Publications

Fatemeh Ghasemzadeh, and Ghasem D Najafpour, and Maedeh Mohammadi
February 2020, Pathogens (Basel, Switzerland),
Fatemeh Ghasemzadeh, and Ghasem D Najafpour, and Maedeh Mohammadi
April 2024, Microbial drug resistance (Larchmont, N.Y.),
Fatemeh Ghasemzadeh, and Ghasem D Najafpour, and Maedeh Mohammadi
August 2016, Applied microbiology and biotechnology,
Fatemeh Ghasemzadeh, and Ghasem D Najafpour, and Maedeh Mohammadi
October 2020, Drug delivery and translational research,
Fatemeh Ghasemzadeh, and Ghasem D Najafpour, and Maedeh Mohammadi
July 2016, Molecules (Basel, Switzerland),
Fatemeh Ghasemzadeh, and Ghasem D Najafpour, and Maedeh Mohammadi
December 2023, Pathogens (Basel, Switzerland),
Fatemeh Ghasemzadeh, and Ghasem D Najafpour, and Maedeh Mohammadi
October 2022, Antibiotics (Basel, Switzerland),
Fatemeh Ghasemzadeh, and Ghasem D Najafpour, and Maedeh Mohammadi
September 2023, BMC biotechnology,
Fatemeh Ghasemzadeh, and Ghasem D Najafpour, and Maedeh Mohammadi
August 2011, Letters in applied microbiology,
Copied contents to your clipboard!